Former Drug Abuse Cmte. Chair Asks FDA To Reconsider Need For Panel

FDA should reconsider its decision to disband the Drug Abuse Advisory Committee, former chair Eric Strain, MD, Johns Hopkins University, suggested during a Peripheral & Central Nervous System Drugs Advisory Committee meeting June 6.